| Literature DB >> 34848401 |
Kiera Louise Adams1, Kate E Saunders2, Charles Donald George Keown-Stoneman3,4, Anne C Duffy5.
Abstract
OBJECTIVE: This study examined the association between candidate psychosocial and lifestyle variables and the trajectories of clinically significant anxiety and depressive symptoms from entry to completion of first-year university.Entities:
Keywords: anxiety disorders; depression & mood disorders; mental health; psychiatry
Mesh:
Year: 2021 PMID: 34848401 PMCID: PMC8666865 DOI: 10.1136/bmjopen-2020-047393
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Flowchart for inclusion in the study and allocation to groups. GADS7, Generalised Anxiety Disorder Questionnaire; PHQ9, Patient Health Questionnaire 9.
Sample demographics
| Total sample | Group 1 | Group 2 | Group 3 | Group 4 | |
| Mean (SD) | |||||
| Age | 18.0 (1.1) | 18.0 (1.1) | 18.0 (1.1) | 18.0 (1.1) | 18.1 (1.1) |
| Early life adversity | 0.5 (0.8) | 0.7 (0.8) | 0.5 (0.7) | 0.8 (0.9) | 0.5 (0.7) |
| Socioeconomic status | 5.2 (1.7) | 5.0 (1.6) | 5.1 (1.6) | 4.9 (1.6) | 5.1 (1.6) |
| University connectedness | 15.8 (6.5) | 15.7 (5.1) | 17.9 (4.6) | 15.0 (5.2) | 18.0 (4.5) |
| Time 1 drug use | 0.7 (1.8) | 0.9 (2.1) | 0.6 (1.5) | 1.2 (2.7) | 0.5 (1.2) |
| Time 2 drug use | 1.3 (2.7) | 1.6 (2.7) | 1.3 (2.6) | 1.8 (2.9) | 1.2 (2.6) |
| Change in drug use | 0.6 (2.8) | 0.6 (2.9) | 0.7 (2.4) | 0.6 (2.9) | 0.7 (2.5) |
| Time 1 alcohol use | 1.7 (1.2) | 1.7 (1.2) | 1.7 (1.2) | 1.8 (1.12) | 1.7 (1.2) |
| Time 2 alcohol use | 1.7 (1.1) | 1.8 (1.1) | 1.7 (1.1) | 1.8 (1.1) | 1.7 (1.1) |
| Change in alcohol use | −0.1 (1.0) | 0.0 (1.0) | 0.0 (1.0) | 0.0 (1.0) | 0.0 (1.0) |
| Time 1 social support | 16.4 (3.9) | 15.7 (3.9) | 16.7 (3.9) | 15.1 (4.0) | 16.8 (3.8) |
| Time 2 social support | 15.1 (5.5) | 14.5 (5.4) | 15.4 (5.5) | 14.0 (5.3) | 15.5 (5.5) |
| Change in social support | −1.2 (5.9) | −1.2 (5.6) | −1.3 (6.1) | −1.1 (5.7) | −1.3 (6.0) |
| Time 1 GAD7 | 7.6 (5.7) | 14.5 (3.5) | 4.3 (2.8) | 13.2 (4.9) | 5.4 (4.2) |
| Time 2 GAD7 | 8.5 (6.1) | 12.4 (5.6) | 6.6 (5.3) | 12.8 (5.8) | 6.9 (5.4) |
| Change in GAD7 | 1.0 (5.6) | −2.0 (5.5) | 2.4 (5.1) | −0.4 (6.2) | 1.5 (5.3) |
| Time 1 PHQ9 | 6.9 (5.7) | 12.0 (5.7) | 4.5 (3.6) | 14.6 (4.2) | 4.1 (2.8) |
| Time 2 PHQ9 | 8.6 (6.1) | 12.0 (6.6) | 6.9 (5.8) | 13.7 (6.7) | 6.7 (5.3) |
| Change in PHQ9 | 1.7 (5.6) | 0.0 (6.3) | 2.4 (5.2) | −0.9 (6.4) | 2.6 (5.0) |
| Percentage | |||||
| Lifetime anxiety/depression | 20.3 | 37.6 | 11.9 | 37.4 | 13.8 |
| Female | 72.0 | 84.4 | 67.5 | 69.7 | 81.0 |
| White | 65.6 | 66.9 | 65.7 | 63.2 | 67.1 |
| Asian | 18.9 | 16.2 | 20.7 | 18.5 | 19.6 |
| Black | 1.6 | 1.1 | 1.7 | 1.8 | 1.5 |
| Other | 13.9 | 15.8 | 11.9 | 16.5 | 11.8 |
| Time 1 attended support | 5.1 | 11.8 | 2.2 | 10.3 | 3.4 |
| Time 2 attended support | 6.8 | 15.1 | 3.2 | 14.7 | 4.3 |
Early life adversity, frequency of drug use and frequency of alcohol use scored from 0 to 4 (4 indicating higher levels).
Group 1 = clinically significant GAD7 score at time 1; Group 2 = no significant GAD7 score at time 1; Group 3 = clinically significant PHQ9 score at time 1; Group 4 = no significant PHQ9 score at time 1.
GADS7, Generalised Anxiety Disorder Questionnaire; PHQ9, Patient Health Questionnaire 9.
Logistic regression results for group 3
| Predictors | ß value | SE | Wald value | P value | OR | 95% CI |
| Gender | −0.15 | 0.36 | −0.43 | 0.668 | 0.86 | 0.43 to 1.73 |
| SES | 0.05 | 0.09 | 0.54 | 0.587 | 1.05 | 0.88 to 1.25 |
| Early life adversity | −0.20 | 0.19 | −1.09 | 0.277 | 0.81 | 0.56 to 1.18 |
| Lifetime disorder * | −1.29 | 0.36 | −3.58 | <0.001 | 0.27 | 0.13 to 0.56 |
| Initial PHQ9 | 0.02 | 0.04 | 0.61 | 0.541 | 1.02 | 0.95 to 1.10 |
| University connectedness * | 0.16 | 0.04 | 4.64 | <0.001 | 1.18 | 1.10 to 1.26 |
| Change in drug use | −0.07 | 0.05 | −1.34 | 0.181 | 0.93 | 0.84 to 1.03 |
| Change in alcohol use | 0.06 | 0.15 | 0.40 | 0.688 | 1.06 | 0.79 to 1.42 |
| Change in social support | 0.06 | 0.03 | 2.21 | 0.028 | 1.06 | 1.01 to 1.12 |
| Change in support utilisation | −1.23 | 0.55 | −2.25 | 0.025 | 0.29 | 0.10 to 0.86 |
R²=0.46 (Nagelkerke). Model χ² (10)=66.56, p<0.001.
*Statistically significant once corrected for multiple comparisons using the Benjamini-Hochberg procedure.
PHQ9, Patient Health Questionnaire 9; SES, socioeconomic status.
Logistic regression results for group 4
| Predictors | ß value | SE | Wald value | P value | OR | 95% CI |
| Gender | −0.01 | 0.19 | −0.09 | 0.929 | 0.98 | 0.67 to 1.44 |
| SES | 0.06 | 0.05 | 1.12 | 0.261 | 1.06 | 0.96 to 1.18 |
| Early life adversity | 0.28 | 0.12 | 2.36 | 0.019 | 1.32 | 1.05 to 1.66 |
| Lifetime disorder | 0.38 | 0.24 | 1.60 | 0.110 | 1.46 | 0.92 to 2.31 |
| Initial PHQ9 | 0.03 | 0.03 | 1.03 | 0.306 | 1.03 | 0.97 to 1.10 |
| University connectedness* | −0.11 | 0.02 | −6.00 | <0.001 | 0.90 | 0.87 to 0.93 |
| Change in drug use * | 0.15 | 0.03 | 4.66 | <0.001 | 1.16 | 1.09 to 1.23 |
| Change in alcohol use | 0.01 | 0.09 | 0.06 | 0.951 | 1.01 | 0.84 to 1.20 |
| Change in social support | −0.03 | 0.01 | −2.30 | 0.021 | 0.97 | 0.94 to 1.00 |
| Change in support utilisation | 0.78 | 0.38 | 2.03 | 0.043 | 2.17 | 1.03 to 4.59 |
R²=0.59 (Nagelkerke). Model χ² (10)=100.74, p<0.001.
*Statistically significant once corrected for multiple comparisons using the Benjamini-Hochberg procedure.
PHQ9, Patient Health Questionnaire 9; SES, socioeconomic status.
Logistic regression results for group 1
| Predictors | ß value | SE | Wald value | P value | OR | 95% CI |
| Gender | −0.08 | 0.30 | −0.28 | 0.780 | 0.92 | 0.51 to 1.67 |
| SES | 0.01 | 0.07 | 0.21 | 0.831 | 1.01 | 0.86 to 1.16 |
| Early life adversity | −0.01 | 0.15 | −0.04 | 0.972 | 0.99 | 0.75 to 1.32 |
| Lifetime disorder * | −1.01 | 0.26 | −3.84 | <0.001 | 0.36 | 0.22 to 0.61 |
| University connectedness * | 0.13 | 0.03 | 4.50 | <0.001 | 1.14 | 1.08 to 1.20 |
| Change in drug use | 0.00 | 0.04 | −0.01 | 0.992 | 1.00 | 0.92 to 1.09 |
| Change in alcohol use | −0.19 | 0.12 | −1.65 | 0.100 | 0.83 | 0.66 to 1.04 |
| Change in support utilisation | −0.75 | 0.36 | −2.08 | 0.038 | 0.47 | 0.23 to 0.96 |
R²=0.45 (Nagelkerke). Model χ² (10)=67.65, p<0.001.
*Statistically significant once corrected for multiple comparisons using the Benjamini-Hochberg procedure.
SES, socioeconomic status.
Restricted cubic spline results for group 1
| L.R. χ² | df | P value | |
| Initial GAD7 | 4.42 | 2 | 0.110 |
| Change in social support | 3.36 | 2 | 0.187 |
*Statistically significant once corrected for multiple comparisons using the Benjamini-Hochberg procedure
df, Degrees of freedom; GADS7, Generalised Anxiety Disorder Questionnaire; L.R., Likelihood ratio.
Logistic regression results for group 2
| Predictors | ß value | SE | Wald value | P value | OR | 95% CI |
| Gender | 0.18 | 0.19 | 0.95 | 0.314 | 1.2 | 0.83 to 1.74 |
| SES | −0.04 | 0.05 | −0.75 | 0.454 | 0.96 | 0.87 to 1.06 |
| Early life adversity | 0.23 | 0.11 | 2.03 | 0.042 | 1.26 | 1.01 to 1.56 |
| Lifetime disorder | 0.30 | 0.24 | 1.26 | 0.207 | 1.35 | 0.85 to 2.15 |
| University connectedness * | −0.07 | 0.02 | −3.85 | <0.001 | 0.94 | 0.91 to 0.97 |
| Change in drug use * | 0.08 | 0.03 | 2.56 | 0.011 | 1.08 | 1.02 to 1.15 |
| Change in alcohol use | −0.12 | 0.09 | −1.36 | 0.173 | 0.89 | 0.75 to 1.05 |
| Change in social support | −0.02 | 0.01 | −1.57 | 0.117 | 0.98 | 0.95 to 1.01 |
| Change in support utilisation* | 1.55 | 0.43 | 3.56 | <0.001 | 4.70 | 2.00 to 11.04 |
R²=0.58 (Nagelkerke). Model χ² (10)=97.01, p<0.001.
*Statistically significant once corrected for multiple comparisons using the Benjamini-Hochberg procedure.
SES, socioeconomic status.
Restricted cubic spline predictors for group 2
| L.R. χ² | df | P value | OR | 95% CI | |
| Initial GAD7* | 6.70 | 2 | <0.001 | ||
| Increase from mean by one point * | 1.17 | 1.10 to 1.25 | |||
| Increase from mean to threshold | 1.29 | 0.78 to 2.16 |
*Statistically significant once corrected for multiple comparisons using the Benjamini-Hochberg procedure.
df, Degrees of freedom; GADS7, Generalised Anxiety Disorder Questionnaire; L.R., Likelihood ratio.